

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 6.41714823 |
| 2 | L-phenylalanine catabolic process (GO:0006559) | 6.41714823 |
| 3 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 6.40394490 |
| 4 | L-phenylalanine metabolic process (GO:0006558) | 6.40394490 |
| 5 | aromatic amino acid family catabolic process (GO:0009074) | 5.74320660 |
| 6 | cysteine metabolic process (GO:0006534) | 5.59770714 |
| 7 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 5.50452664 |
| 8 | urea metabolic process (GO:0019627) | 5.33775294 |
| 9 | urea cycle (GO:0000050) | 5.33775294 |
| 10 | kynurenine metabolic process (GO:0070189) | 5.21076557 |
| 11 | indolalkylamine catabolic process (GO:0046218) | 5.12166975 |
| 12 | tryptophan catabolic process (GO:0006569) | 5.12166975 |
| 13 | indole-containing compound catabolic process (GO:0042436) | 5.12166975 |
| 14 | glyoxylate metabolic process (GO:0046487) | 5.11519488 |
| 15 | glycine metabolic process (GO:0006544) | 5.10416188 |
| 16 | sulfur amino acid catabolic process (GO:0000098) | 5.04325939 |
| 17 | nuclear pore complex assembly (GO:0051292) | 5.03475895 |
| 18 | serine family amino acid catabolic process (GO:0009071) | 5.02971573 |
| 19 | homocysteine metabolic process (GO:0050667) | 4.99661454 |
| 20 | bile acid biosynthetic process (GO:0006699) | 4.99147765 |
| 21 | negative regulation of fibrinolysis (GO:0051918) | 4.98170116 |
| 22 | alpha-linolenic acid metabolic process (GO:0036109) | 4.95239412 |
| 23 | tryptophan metabolic process (GO:0006568) | 4.93092711 |
| 24 | high-density lipoprotein particle remodeling (GO:0034375) | 4.82433490 |
| 25 | nitrogen cycle metabolic process (GO:0071941) | 4.80962342 |
| 26 | lysine catabolic process (GO:0006554) | 4.76207346 |
| 27 | lysine metabolic process (GO:0006553) | 4.76207346 |
| 28 | DNA unwinding involved in DNA replication (GO:0006268) | 4.75185736 |
| 29 | formation of translation preinitiation complex (GO:0001731) | 4.71056208 |
| 30 | serine family amino acid biosynthetic process (GO:0009070) | 4.64029949 |
| 31 | serine family amino acid metabolic process (GO:0009069) | 4.58008475 |
| 32 | regulation of fibrinolysis (GO:0051917) | 4.54951492 |
| 33 | negative regulation of sterol transport (GO:0032372) | 4.54421451 |
| 34 | negative regulation of cholesterol transport (GO:0032375) | 4.54421451 |
| 35 | nuclear pore organization (GO:0006999) | 4.54271264 |
| 36 | regulation of protein activation cascade (GO:2000257) | 4.50193985 |
| 37 | protein carboxylation (GO:0018214) | 4.37520226 |
| 38 | peptidyl-glutamic acid carboxylation (GO:0017187) | 4.37520226 |
| 39 | aromatic amino acid family metabolic process (GO:0009072) | 4.35416542 |
| 40 | bile acid metabolic process (GO:0008206) | 4.33249926 |
| 41 | bile acid and bile salt transport (GO:0015721) | 4.30346896 |
| 42 | complement activation, alternative pathway (GO:0006957) | 4.29341649 |
| 43 | reverse cholesterol transport (GO:0043691) | 4.20874124 |
| 44 | regulation of complement activation (GO:0030449) | 4.20041427 |
| 45 | alpha-amino acid catabolic process (GO:1901606) | 4.18370378 |
| 46 | tyrosine metabolic process (GO:0006570) | 4.17228675 |
| 47 | imidazole-containing compound metabolic process (GO:0052803) | 4.16231399 |
| 48 | ribosomal small subunit biogenesis (GO:0042274) | 4.12921467 |
| 49 | ribosomal small subunit assembly (GO:0000028) | 4.10032722 |
| 50 | one-carbon metabolic process (GO:0006730) | 4.05485966 |
| 51 | regulation of triglyceride catabolic process (GO:0010896) | 4.04126938 |
| 52 | protein-lipid complex remodeling (GO:0034368) | 4.04083310 |
| 53 | macromolecular complex remodeling (GO:0034367) | 4.04083310 |
| 54 | plasma lipoprotein particle remodeling (GO:0034369) | 4.04083310 |
| 55 | nucleobase-containing small molecule interconversion (GO:0015949) | 4.02157235 |
| 56 | protein complex localization (GO:0031503) | 4.00326836 |
| 57 | amino-acid betaine metabolic process (GO:0006577) | 3.98630911 |
| 58 | triglyceride homeostasis (GO:0070328) | 3.97687694 |
| 59 | acylglycerol homeostasis (GO:0055090) | 3.97687694 |
| 60 | cellular modified amino acid catabolic process (GO:0042219) | 3.96040157 |
| 61 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.95821806 |
| 62 | regulation of translational fidelity (GO:0006450) | 3.94972422 |
| 63 | DNA strand elongation involved in DNA replication (GO:0006271) | 3.93946438 |
| 64 | cellular ketone body metabolic process (GO:0046950) | 3.91933806 |
| 65 | peptidyl-arginine omega-N-methylation (GO:0035247) | 3.91245746 |
| 66 | glutamate metabolic process (GO:0006536) | 3.89576294 |
| 67 | cellular amino acid catabolic process (GO:0009063) | 3.88780770 |
| 68 | DNA strand elongation (GO:0022616) | 3.88440451 |
| 69 | regulation of cholesterol esterification (GO:0010872) | 3.85687983 |
| 70 | establishment of integrated proviral latency (GO:0075713) | 3.85005991 |
| 71 | COPI coating of Golgi vesicle (GO:0048205) | 3.84107738 |
| 72 | Golgi transport vesicle coating (GO:0048200) | 3.84107738 |
| 73 | folic acid metabolic process (GO:0046655) | 3.78066696 |
| 74 | pore complex assembly (GO:0046931) | 3.77861065 |
| 75 | folic acid-containing compound biosynthetic process (GO:0009396) | 3.74659692 |
| 76 | drug catabolic process (GO:0042737) | 3.71205437 |
| 77 | ethanol oxidation (GO:0006069) | 3.69739467 |
| 78 | histone arginine methylation (GO:0034969) | 3.66885443 |
| 79 | cellular glucuronidation (GO:0052695) | 3.65937026 |
| 80 | phospholipid efflux (GO:0033700) | 3.65565908 |
| 81 | arginine metabolic process (GO:0006525) | 3.63859395 |
| 82 | intestinal cholesterol absorption (GO:0030299) | 3.63247722 |
| 83 | negative regulation of mRNA splicing, via spliceosome (GO:0048025) | 3.63124611 |
| 84 | viral transcription (GO:0019083) | 3.61913303 |
| 85 | tetrahydrofolate metabolic process (GO:0046653) | 3.61637877 |
| 86 | plasma lipoprotein particle clearance (GO:0034381) | 3.61022462 |
| 87 | proline biosynthetic process (GO:0006561) | 3.60992573 |
| 88 | regulation of cholesterol homeostasis (GO:2000188) | 3.60327425 |
| 89 | indolalkylamine metabolic process (GO:0006586) | 3.59362248 |
| 90 | maturation of SSU-rRNA (GO:0030490) | 3.56991911 |
| 91 | benzene-containing compound metabolic process (GO:0042537) | 3.54261001 |
| 92 | mitotic chromosome condensation (GO:0007076) | 3.54103682 |
| 93 | ribosomal large subunit biogenesis (GO:0042273) | 3.53539207 |
| 94 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.52177932 |
| 95 | DNA replication initiation (GO:0006270) | 3.51176475 |
| 96 | translational termination (GO:0006415) | 3.49645717 |
| 97 | plasma lipoprotein particle assembly (GO:0034377) | 3.48932656 |
| 98 | ribosome assembly (GO:0042255) | 3.48221215 |
| 99 | cellular protein complex localization (GO:0034629) | 3.46303510 |
| 100 | aldehyde catabolic process (GO:0046185) | 3.45806260 |
| 101 | coenzyme catabolic process (GO:0009109) | 3.45465705 |
| 102 | ketone body metabolic process (GO:1902224) | 3.44532473 |
| 103 | urate metabolic process (GO:0046415) | 3.42562932 |
| 104 | L-serine metabolic process (GO:0006563) | 3.41895441 |
| 105 | ribonucleoprotein complex biogenesis (GO:0022613) | 3.40831009 |
| 106 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184) | 3.40549818 |
| 107 | spliceosomal tri-snRNP complex assembly (GO:0000244) | 3.39453493 |
| 108 | cholesterol efflux (GO:0033344) | 3.37544162 |
| 109 | response to nitrosative stress (GO:0051409) | 3.37249086 |
| 110 | amine catabolic process (GO:0009310) | 3.32028042 |
| 111 | cellular biogenic amine catabolic process (GO:0042402) | 3.32028042 |
| 112 | negative regulation of fatty acid biosynthetic process (GO:0045717) | 3.30428085 |
| 113 | acetyl-CoA metabolic process (GO:0006084) | 3.30212648 |
| 114 | telomere maintenance via semi-conservative replication (GO:0032201) | 3.30049171 |
| 115 | drug transmembrane transport (GO:0006855) | 3.28647162 |
| 116 | pyrimidine nucleobase catabolic process (GO:0006208) | 3.28061635 |
| 117 | translational initiation (GO:0006413) | 3.25931843 |
| 118 | lipoprotein metabolic process (GO:0042157) | 3.24980875 |
| 119 | purine nucleobase biosynthetic process (GO:0009113) | 3.23321028 |
| 120 | cholesterol homeostasis (GO:0042632) | 3.23017707 |
| 121 | regulation of bile acid biosynthetic process (GO:0070857) | 3.22797437 |
| 122 | ribosome biogenesis (GO:0042254) | 3.22542269 |
| 123 | mitotic sister chromatid segregation (GO:0000070) | 3.22500557 |
| 124 | peptidyl-arginine N-methylation (GO:0035246) | 3.21654367 |
| 125 | peptidyl-arginine methylation (GO:0018216) | 3.21654367 |
| 126 | IMP biosynthetic process (GO:0006188) | 3.21580084 |
| 127 | uronic acid metabolic process (GO:0006063) | 3.21540748 |
| 128 | glucuronate metabolic process (GO:0019585) | 3.21540748 |
| 129 | sterol homeostasis (GO:0055092) | 3.21419687 |
| 130 | organic acid catabolic process (GO:0016054) | 3.21086107 |
| 131 | carboxylic acid catabolic process (GO:0046395) | 3.21086107 |
| 132 | fibrinolysis (GO:0042730) | 3.20335517 |
| 133 | 2-oxoglutarate metabolic process (GO:0006103) | 3.19836238 |
| 134 | translational elongation (GO:0006414) | 3.19821807 |
| 135 | heme transport (GO:0015886) | 3.19332014 |
| 136 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.18698519 |
| 137 | negative regulation of RNA splicing (GO:0033119) | 3.18564837 |
| 138 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 3.18286434 |
| 139 | aspartate family amino acid catabolic process (GO:0009068) | 3.18279607 |
| 140 | negative regulation of mRNA processing (GO:0050686) | 3.17685482 |
| 141 | intestinal absorption (GO:0050892) | 3.17437425 |
| 142 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.15849199 |
| 143 | mitotic metaphase plate congression (GO:0007080) | 3.15474757 |
| 144 | protein localization to chromosome, centromeric region (GO:0071459) | 3.14035769 |
| 145 | establishment of viral latency (GO:0019043) | 3.13245009 |
| 146 | cotranslational protein targeting to membrane (GO:0006613) | 3.11368002 |
| 147 | protein targeting to ER (GO:0045047) | 3.09707406 |
| 148 | regulation of attachment of spindle microtubules to kinetochore (GO:0051988) | 3.08681859 |
| 149 | tRNA aminoacylation for protein translation (GO:0006418) | 3.07926675 |
| 150 | negative regulation of mRNA metabolic process (GO:1903312) | 3.06757733 |
| 151 | mitotic nuclear envelope disassembly (GO:0007077) | 3.06202858 |
| 152 | viral life cycle (GO:0019058) | 3.05095644 |
| 153 | protein export from nucleus (GO:0006611) | 3.04929027 |
| 154 | amino acid activation (GO:0043038) | 3.00074845 |
| 155 | tRNA aminoacylation (GO:0043039) | 3.00074845 |
| 156 | regulation of mammary gland epithelial cell proliferation (GO:0033599) | 2.99544592 |
| 157 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 2.98793206 |
| 158 | viral mRNA export from host cell nucleus (GO:0046784) | 2.97987225 |
| 159 | regulation of translational termination (GO:0006449) | 2.97481327 |
| 160 | sister chromatid segregation (GO:0000819) | 2.96136482 |
| 161 | protein localization to endoplasmic reticulum (GO:0070972) | 2.93358884 |
| 162 | DNA topological change (GO:0006265) | 2.92306929 |
| 163 | nuclear envelope disassembly (GO:0051081) | 2.90641145 |
| 164 | membrane disassembly (GO:0030397) | 2.90641145 |
| 165 | cellular protein complex disassembly (GO:0043624) | 2.90521050 |
| 166 | positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling | 2.90082613 |
| 167 | IMP metabolic process (GO:0046040) | 2.89756680 |
| 168 | nucleobase biosynthetic process (GO:0046112) | 2.88030899 |
| 169 | regulation of mitochondrial translation (GO:0070129) | 2.87031180 |
| 170 | protein targeting to mitochondrion (GO:0006626) | 2.84125468 |
| 171 | deoxyribonucleotide biosynthetic process (GO:0009263) | 2.83093580 |
| 172 | protein complex disassembly (GO:0043241) | 2.81413024 |
| 173 | guanosine-containing compound biosynthetic process (GO:1901070) | 2.80980297 |
| 174 | mitotic sister chromatid cohesion (GO:0007064) | 2.77373989 |
| 175 | DNA duplex unwinding (GO:0032508) | 2.76878584 |
| 176 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 2.76419578 |
| 177 | telomere maintenance via recombination (GO:0000722) | 2.71971621 |
| 178 | translation (GO:0006412) | 2.69866925 |
| 179 | GDP-mannose metabolic process (GO:0019673) | 2.69268390 |
| 180 | rRNA processing (GO:0006364) | 2.69009296 |
| 181 | macromolecular complex disassembly (GO:0032984) | 2.68694547 |
| 182 | deoxyribose phosphate biosynthetic process (GO:0046385) | 2.68585344 |
| 183 | 2-deoxyribonucleotide biosynthetic process (GO:0009265) | 2.68585344 |
| 184 | termination of RNA polymerase II transcription (GO:0006369) | 2.68289098 |
| 185 | double-strand break repair via nonhomologous end joining (GO:0006303) | 2.67854089 |
| 186 | non-recombinational repair (GO:0000726) | 2.67854089 |
| 187 | protein maturation by protein folding (GO:0022417) | 2.67763959 |
| 188 | protoporphyrinogen IX metabolic process (GO:0046501) | 2.66736034 |
| 189 | regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway | 2.64667347 |
| 190 | positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling | 2.64667347 |
| 191 | regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083) | 2.64235225 |
| 192 | oxidative phosphorylation (GO:0006119) | 2.64104746 |
| 193 | pentose-phosphate shunt (GO:0006098) | 2.63622661 |
| 194 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 2.63221124 |
| 195 | spliceosomal snRNP assembly (GO:0000387) | 2.62749701 |
| 196 | DNA geometric change (GO:0032392) | 2.62511788 |
| 197 | chromatin remodeling at centromere (GO:0031055) | 2.61773309 |
| 198 | rRNA transcription (GO:0009303) | 2.61656334 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 8.72089509 |
| 2 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 5.87489186 |
| 3 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 5.32194313 |
| 4 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 4.52952801 |
| 5 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 4.29274395 |
| 6 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 3.86085016 |
| 7 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 3.55895926 |
| 8 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 3.53125445 |
| 9 | E2F7_22180533_ChIP-Seq_HELA_Human | 3.43443705 |
| 10 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 3.21170817 |
| 11 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 3.10713374 |
| 12 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.64875424 |
| 13 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 2.45667824 |
| 14 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 2.41225939 |
| 15 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.41087035 |
| 16 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 2.40420506 |
| 17 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 2.33234284 |
| 18 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 2.15384376 |
| 19 | AR_21909140_ChIP-Seq_LNCAP_Human | 2.15326251 |
| 20 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.09217783 |
| 21 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.93159813 |
| 22 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.89606262 |
| 23 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.87707417 |
| 24 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.86240677 |
| 25 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.82543753 |
| 26 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.79421822 |
| 27 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.74972993 |
| 28 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.70270707 |
| 29 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.68920696 |
| 30 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.68418443 |
| 31 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.63443747 |
| 32 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.60074246 |
| 33 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.59169115 |
| 34 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.58274866 |
| 35 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.57771947 |
| 36 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.56570006 |
| 37 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.55822514 |
| 38 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.51905602 |
| 39 | * MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.51669100 |
| 40 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.50589779 |
| 41 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.50493821 |
| 42 | * CREM_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.49532072 |
| 43 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.48931255 |
| 44 | * CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.48570859 |
| 45 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.47782313 |
| 46 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.46093523 |
| 47 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.44453647 |
| 48 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.44109263 |
| 49 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.42685465 |
| 50 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.42623915 |
| 51 | * ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.41794955 |
| 52 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.35905661 |
| 53 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.35623549 |
| 54 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.35526560 |
| 55 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.34230085 |
| 56 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.34082576 |
| 57 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.33708749 |
| 58 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.33288642 |
| 59 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.32454327 |
| 60 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.30134283 |
| 61 | E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 1.30009195 |
| 62 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.29902916 |
| 63 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.29521143 |
| 64 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.28279638 |
| 65 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.26674806 |
| 66 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.25162612 |
| 67 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.25002062 |
| 68 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.24561953 |
| 69 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.23878281 |
| 70 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.23868251 |
| 71 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.23204817 |
| 72 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.21858652 |
| 73 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.21093362 |
| 74 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.19707767 |
| 75 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.15787438 |
| 76 | * ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.15645998 |
| 77 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.15168490 |
| 78 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.13524320 |
| 79 | ATF3_27146783_Chip-Seq_COLON_Human | 1.10864094 |
| 80 | * DCP1A_22483619_ChIP-Seq_HELA_Human | 1.08743229 |
| 81 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 1.08437366 |
| 82 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.07701350 |
| 83 | KLF4_19030024_ChIP-ChIP_MESCs_Mouse | 1.07469949 |
| 84 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.06278459 |
| 85 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.04181191 |
| 86 | * GATA6_25053715_ChIP-Seq_YYC3_Human | 1.03579603 |
| 87 | TRIM28_19339689_ChIP-ChIP_MESCs_Mouse | 1.03496658 |
| 88 | * JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.02691152 |
| 89 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.02561472 |
| 90 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.01717903 |
| 91 | TBX5_21415370_ChIP-Seq_HL-1_Mouse | 1.01019090 |
| 92 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.00506949 |
| 93 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.99321096 |
| 94 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 0.99162629 |
| 95 | CHD1_26751641_Chip-Seq_LNCaP_Human | 0.99150970 |
| 96 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.98601034 |
| 97 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.98087039 |
| 98 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 0.97658366 |
| 99 | * KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 0.97144395 |
| 100 | NANOG_21062744_ChIP-ChIP_HESCs_Human | 0.97029202 |
| 101 | MYC_22102868_ChIP-Seq_BL_Human | 0.96482493 |
| 102 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 0.96390546 |
| 103 | PKCTHETA_26484144_Chip-Seq_BREAST_Human | 0.95670945 |
| 104 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 0.95573406 |
| 105 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.94541308 |
| 106 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 0.94051494 |
| 107 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.93280440 |
| 108 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.93204569 |
| 109 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 0.91731545 |
| 110 | TCFCP2L1_18555785_ChIP-Seq_MESCs_Mouse | 0.91564281 |
| 111 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.91322524 |
| 112 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.91182013 |
| 113 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 0.90149506 |
| 114 | OCT4_18692474_ChIP-Seq_MEFs_Mouse | 0.90104585 |
| 115 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.87990682 |
| 116 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.86961790 |
| 117 | SOX2_18692474_ChIP-Seq_MEFs_Mouse | 0.86152228 |
| 118 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.85782617 |
| 119 | * RXRA_24833708_ChIP-Seq_LIVER_Mouse | 0.85579888 |
| 120 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 0.83717417 |
| 121 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.83137947 |
| 122 | SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 0.82483639 |
| 123 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 0.80099045 |
| 124 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.78912214 |
| 125 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 0.78677687 |
| 126 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 0.78386820 |
| 127 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.77227753 |
| 128 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 0.76379398 |
| 129 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.76289203 |
| 130 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.76183796 |
| 131 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.76148948 |
| 132 | NACC1_18358816_ChIP-ChIP_MESCs_Mouse | 0.76034478 |
| 133 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 0.75387688 |
| 134 | * RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.74958328 |
| 135 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.74148117 |
| 136 | * CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 0.73665586 |
| 137 | CNOT3_19339689_ChIP-ChIP_MESCs_Mouse | 0.73312439 |
| 138 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.72891122 |
| 139 | SOX2_18555785_ChIP-Seq_MESCs_Mouse | 0.72572769 |
| 140 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 0.71746004 |
| 141 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 0.71576596 |
| 142 | * CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 0.71112753 |
| 143 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 0.70890962 |
| 144 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.70756481 |
| 145 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.69417944 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 7.68530131 |
| 2 | MP0005360_urolithiasis | 7.07462274 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 5.72051048 |
| 4 | MP0005365_abnormal_bile_salt | 5.67788183 |
| 5 | MP0003806_abnormal_nucleotide_metabolis | 4.34107814 |
| 6 | MP0008875_abnormal_xenobiotic_pharmacok | 4.20947043 |
| 7 | MP0003252_abnormal_bile_duct | 3.38209034 |
| 8 | MP0008057_abnormal_DNA_replication | 3.23769355 |
| 9 | MP0010329_abnormal_lipoprotein_level | 3.09708309 |
| 10 | MP0001666_abnormal_nutrient_absorption | 2.93487950 |
| 11 | MP0010234_abnormal_vibrissa_follicle | 2.87830330 |
| 12 | MP0009840_abnormal_foam_cell | 2.76584670 |
| 13 | MP0005083_abnormal_biliary_tract | 2.75467109 |
| 14 | MP0008058_abnormal_DNA_repair | 2.72848259 |
| 15 | MP0008932_abnormal_embryonic_tissue | 2.71725391 |
| 16 | MP0005332_abnormal_amino_acid | 2.54165626 |
| 17 | MP0003705_abnormal_hypodermis_morpholog | 2.46231961 |
| 18 | MP0002877_abnormal_melanocyte_morpholog | 2.30452288 |
| 19 | MP0008007_abnormal_cellular_replicative | 2.28156409 |
| 20 | MP0002009_preneoplasia | 2.13257155 |
| 21 | MP0004147_increased_porphyrin_level | 2.05984561 |
| 22 | MP0000609_abnormal_liver_physiology | 2.00500920 |
| 23 | MP0004019_abnormal_vitamin_homeostasis | 2.00407528 |
| 24 | MP0003868_abnormal_feces_composition | 1.98174083 |
| 25 | MP0005501_abnormal_skin_physiology | 1.96315983 |
| 26 | MP0008260_abnormal_autophagy | 1.88909738 |
| 27 | MP0003786_premature_aging | 1.88818823 |
| 28 | MP0003195_calcinosis | 1.88218835 |
| 29 | MP0003941_abnormal_skin_development | 1.82294233 |
| 30 | MP0004185_abnormal_adipocyte_glucose | 1.81882920 |
| 31 | MP0002138_abnormal_hepatobiliary_system | 1.75891891 |
| 32 | MP0000313_abnormal_cell_death | 1.74331075 |
| 33 | MP0005319_abnormal_enzyme/_coenzyme | 1.73997915 |
| 34 | MP0010352_gastrointestinal_tract_polyps | 1.65172582 |
| 35 | MP0002118_abnormal_lipid_homeostasis | 1.63470424 |
| 36 | MP0000490_abnormal_crypts_of | 1.60942398 |
| 37 | MP0001346_abnormal_lacrimal_gland | 1.58534290 |
| 38 | MP0009053_abnormal_anal_canal | 1.56579301 |
| 39 | MP0004233_abnormal_muscle_weight | 1.54634320 |
| 40 | MP0003693_abnormal_embryo_hatching | 1.50934919 |
| 41 | MP0001764_abnormal_homeostasis | 1.47911144 |
| 42 | MP0002396_abnormal_hematopoietic_system | 1.43880741 |
| 43 | MP0003191_abnormal_cellular_cholesterol | 1.40037105 |
| 44 | MP0009697_abnormal_copulation | 1.34994068 |
| 45 | MP0009643_abnormal_urine_homeostasis | 1.33359599 |
| 46 | MP0002085_abnormal_embryonic_tissue | 1.31283691 |
| 47 | MP0000598_abnormal_liver_morphology | 1.28835382 |
| 48 | MP0004264_abnormal_extraembryonic_tissu | 1.25383242 |
| 49 | MP0003186_abnormal_redox_activity | 1.24104791 |
| 50 | MP0001727_abnormal_embryo_implantation | 1.20274371 |
| 51 | MP0001188_hyperpigmentation | 1.19527321 |
| 52 | MP0008995_early_reproductive_senescence | 1.19045888 |
| 53 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.13796824 |
| 54 | MP0005220_abnormal_exocrine_pancreas | 1.13465216 |
| 55 | MP0003656_abnormal_erythrocyte_physiolo | 1.12690378 |
| 56 | MP0000537_abnormal_urethra_morphology | 1.11988285 |
| 57 | MP0004957_abnormal_blastocyst_morpholog | 1.11521039 |
| 58 | MP0002019_abnormal_tumor_incidence | 1.07916060 |
| 59 | MP0004782_abnormal_surfactant_physiolog | 1.06367070 |
| 60 | MP0005384_cellular_phenotype | 1.05799752 |
| 61 | MP0005408_hypopigmentation | 1.05197726 |
| 62 | MP0005621_abnormal_cell_physiology | 1.01820406 |
| 63 | MP0009703_decreased_birth_body | 0.99772800 |
| 64 | MP0005647_abnormal_sex_gland | 0.97602749 |
| 65 | MP0002098_abnormal_vibrissa_morphology | 0.94467774 |
| 66 | MP0003718_maternal_effect | 0.94443190 |
| 67 | MP0005636_abnormal_mineral_homeostasis | 0.93377086 |
| 68 | MP0000627_abnormal_mammary_gland | 0.92608375 |
| 69 | MP0003890_abnormal_embryonic-extraembry | 0.92268913 |
| 70 | MP0000678_abnormal_parathyroid_gland | 0.92037823 |
| 71 | MP0009379_abnormal_foot_pigmentation | 0.90007916 |
| 72 | MP0004808_abnormal_hematopoietic_stem | 0.89779627 |
| 73 | MP0000377_abnormal_hair_follicle | 0.88978910 |
| 74 | MP0001730_embryonic_growth_arrest | 0.88725635 |
| 75 | MP0009333_abnormal_splenocyte_physiolog | 0.87079349 |
| 76 | MP0001756_abnormal_urination | 0.86128767 |
| 77 | MP0005084_abnormal_gallbladder_morpholo | 0.85984448 |
| 78 | MP0000703_abnormal_thymus_morphology | 0.85754138 |
| 79 | MP0003453_abnormal_keratinocyte_physiol | 0.84107735 |
| 80 | MP0009672_abnormal_birth_weight | 0.83464539 |
| 81 | MP0001216_abnormal_epidermal_layer | 0.80620986 |
| 82 | MP0000604_amyloidosis | 0.78935469 |
| 83 | MP0002210_abnormal_sex_determination | 0.78739737 |
| 84 | MP0006035_abnormal_mitochondrial_morpho | 0.78363688 |
| 85 | MP0001873_stomach_inflammation | 0.77988359 |
| 86 | MP0001661_extended_life_span | 0.77457878 |
| 87 | MP0005451_abnormal_body_composition | 0.75948875 |
| 88 | MP0001145_abnormal_male_reproductive | 0.73807253 |
| 89 | MP0009642_abnormal_blood_homeostasis | 0.72456246 |
| 90 | MP0002160_abnormal_reproductive_system | 0.71006740 |
| 91 | MP0003111_abnormal_nucleus_morphology | 0.70969822 |
| 92 | MP0006036_abnormal_mitochondrial_physio | 0.70755407 |
| 93 | MP0002697_abnormal_eye_size | 0.70137119 |
| 94 | MP0009765_abnormal_xenobiotic_induced | 0.69881204 |
| 95 | MP0005187_abnormal_penis_morphology | 0.69514449 |
| 96 | MP0005376_homeostasis/metabolism_phenot | 0.69387606 |
| 97 | MP0009931_abnormal_skin_appearance | 0.69053173 |
| 98 | MP0006054_spinal_hemorrhage | 0.67360117 |
| 99 | MP0001929_abnormal_gametogenesis | 0.66840005 |
| 100 | MP0000462_abnormal_digestive_system | 0.66813152 |
| 101 | MP0002254_reproductive_system_inflammat | 0.66741130 |
| 102 | MP0005266_abnormal_metabolism | 0.66724401 |
| 103 | MP0002111_abnormal_tail_morphology | 0.66548250 |
| 104 | MP0005248_abnormal_Harderian_gland | 0.65025743 |
| 105 | MP0009763_increased_sensitivity_to | 0.64788429 |
| 106 | MP0002078_abnormal_glucose_homeostasis | 0.63991072 |
| 107 | MP0009764_decreased_sensitivity_to | 0.63840068 |
| 108 | MP0005075_abnormal_melanosome_morpholog | 0.62243334 |
| 109 | MP0003119_abnormal_digestive_system | 0.61836294 |
| 110 | MP0003861_abnormal_nervous_system | 0.61499836 |
| 111 | MP0003077_abnormal_cell_cycle | 0.60647024 |
| 112 | MP0002086_abnormal_extraembryonic_tissu | 0.60560264 |
| 113 | MP0001919_abnormal_reproductive_system | 0.60331695 |
| 114 | MP0005076_abnormal_cell_differentiation | 0.60083000 |
| 115 | MP0005666_abnormal_adipose_tissue | 0.59957464 |
| 116 | MP0010771_integument_phenotype | 0.59950709 |
| 117 | MP0005380_embryogenesis_phenotype | 0.58991568 |
| 118 | MP0001672_abnormal_embryogenesis/_devel | 0.58991568 |
| 119 | MP0001853_heart_inflammation | 0.57987611 |
| 120 | MP0001348_abnormal_lacrimal_gland | 0.57164369 |
| 121 | MP0004270_analgesia | 0.56221991 |
| 122 | MP0002136_abnormal_kidney_physiology | 0.55597335 |
| 123 | MP0003011_delayed_dark_adaptation | 0.55490694 |
| 124 | MP0002088_abnormal_embryonic_growth/wei | 0.55451237 |
| 125 | MP0008873_increased_physiological_sensi | 0.55317644 |
| 126 | MP0002080_prenatal_lethality | 0.54876082 |
| 127 | MP0004197_abnormal_fetal_growth/weight/ | 0.54644257 |
| 128 | MP0002249_abnormal_larynx_morphology | 0.54258259 |
| 129 | MP0001697_abnormal_embryo_size | 0.54157042 |
| 130 | MP0003984_embryonic_growth_retardation | 0.53909472 |
| 131 | MP0008469_abnormal_protein_level | 0.53722442 |
| 132 | MP0005395_other_phenotype | 0.53609114 |
| 133 | MP0001529_abnormal_vocalization | 0.53607724 |
| 134 | MP0000653_abnormal_sex_gland | 0.53029608 |
| 135 | MP0001915_intracranial_hemorrhage | 0.52923201 |
| 136 | MP0001340_abnormal_eyelid_morphology | 0.52169486 |
| 137 | MP0000358_abnormal_cell_content/ | 0.51839919 |
| 138 | MP0010307_abnormal_tumor_latency | 0.49742569 |
| 139 | MP0001881_abnormal_mammary_gland | 0.49316103 |
| 140 | MP0000477_abnormal_intestine_morphology | 0.48971741 |
| 141 | MP0000350_abnormal_cell_proliferation | 0.48791817 |
| 142 | MP0002796_impaired_skin_barrier | 0.48027506 |
| 143 | MP0005023_abnormal_wound_healing | 0.46729935 |
| 144 | MP0003300_gastrointestinal_ulcer | 0.46382762 |
| 145 | MP0001849_ear_inflammation | 0.45535702 |
| 146 | MP0010094_abnormal_chromosome_stability | 0.45025431 |
| 147 | MP0003567_abnormal_fetal_cardiomyocyte | 0.42793302 |
| 148 | MP0003221_abnormal_cardiomyocyte_apopto | 0.42016604 |
| 149 | MP0003638_abnormal_response/metabolism_ | 0.40885776 |
| 150 | MP0005334_abnormal_fat_pad | 0.40655762 |
| 151 | MP0001944_abnormal_pancreas_morphology | 0.39400725 |
| 152 | MP0000538_abnormal_urinary_bladder | 0.39078394 |
| 153 | MP0003123_paternal_imprinting | 0.39047083 |
| 154 | MP0002084_abnormal_developmental_patter | 0.38409265 |
| 155 | MP0002928_abnormal_bile_duct | 0.38403289 |
| 156 | MP0002135_abnormal_kidney_morphology | 0.37360918 |
| 157 | MP0003699_abnormal_female_reproductive | 0.36897319 |
| 158 | MP0008872_abnormal_physiological_respon | 0.36658874 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 6.64550380 |
| 2 | Intrahepatic cholestasis (HP:0001406) | 6.54406764 |
| 3 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 6.50108771 |
| 4 | Hypobetalipoproteinemia (HP:0003563) | 6.41711895 |
| 5 | Deep venous thrombosis (HP:0002625) | 6.38587711 |
| 6 | Xanthomatosis (HP:0000991) | 5.67735379 |
| 7 | Prolonged partial thromboplastin time (HP:0003645) | 5.07840345 |
| 8 | Hypolipoproteinemia (HP:0010981) | 4.67905715 |
| 9 | Hyperlipoproteinemia (HP:0010980) | 4.65004705 |
| 10 | Hyperammonemia (HP:0001987) | 4.35384068 |
| 11 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 4.25306325 |
| 12 | Complement deficiency (HP:0004431) | 4.20179540 |
| 13 | Hyperglycinemia (HP:0002154) | 4.20116184 |
| 14 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 4.20031787 |
| 15 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 4.13594598 |
| 16 | Abnormality of pyrimidine metabolism (HP:0004353) | 4.13485352 |
| 17 | Abnormality of the common coagulation pathway (HP:0010990) | 3.93751841 |
| 18 | Hyperglycinuria (HP:0003108) | 3.92797595 |
| 19 | Epidermoid cyst (HP:0200040) | 3.88176709 |
| 20 | Fat malabsorption (HP:0002630) | 3.85176229 |
| 21 | Ketosis (HP:0001946) | 3.82788212 |
| 22 | Hypoalphalipoproteinemia (HP:0003233) | 3.82212527 |
| 23 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 3.74813548 |
| 24 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.69449127 |
| 25 | Abnormality of glycine metabolism (HP:0010895) | 3.69449127 |
| 26 | Abnormality of methionine metabolism (HP:0010901) | 3.57990849 |
| 27 | Abnormality of the intrinsic pathway (HP:0010989) | 3.54031680 |
| 28 | Spastic diplegia (HP:0001264) | 3.49714326 |
| 29 | Hypoglycemic coma (HP:0001325) | 3.44677369 |
| 30 | Progressive muscle weakness (HP:0003323) | 3.43916287 |
| 31 | Microvesicular hepatic steatosis (HP:0001414) | 3.37494743 |
| 32 | Conjugated hyperbilirubinemia (HP:0002908) | 3.33361041 |
| 33 | Hepatocellular carcinoma (HP:0001402) | 3.27686490 |
| 34 | Reticulocytopenia (HP:0001896) | 3.26024463 |
| 35 | Abnormality of complement system (HP:0005339) | 3.17746205 |
| 36 | Abnormality of nucleobase metabolism (HP:0010932) | 3.17640968 |
| 37 | Joint hemorrhage (HP:0005261) | 3.04030442 |
| 38 | Hyperbilirubinemia (HP:0002904) | 3.02113028 |
| 39 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 3.02029651 |
| 40 | Hypercholesterolemia (HP:0003124) | 2.99907249 |
| 41 | Progressive external ophthalmoplegia (HP:0000590) | 2.91506865 |
| 42 | Delayed CNS myelination (HP:0002188) | 2.89871848 |
| 43 | Abnormality of serum amino acid levels (HP:0003112) | 2.87429274 |
| 44 | Ketoacidosis (HP:0001993) | 2.85072472 |
| 45 | Gout (HP:0001997) | 2.81772631 |
| 46 | Malnutrition (HP:0004395) | 2.78476426 |
| 47 | Chromsome breakage (HP:0040012) | 2.77736932 |
| 48 | Steatorrhea (HP:0002570) | 2.71996925 |
| 49 | Abnormality of cells of the erythroid lineage (HP:0012130) | 2.70094208 |
| 50 | Abnormality of purine metabolism (HP:0004352) | 2.69718776 |
| 51 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.67341282 |
| 52 | Hypochromic microcytic anemia (HP:0004840) | 2.66674196 |
| 53 | Asymmetry of the thorax (HP:0001555) | 2.65638214 |
| 54 | Macrocytic anemia (HP:0001972) | 2.62487661 |
| 55 | Selective tooth agenesis (HP:0001592) | 2.62486736 |
| 56 | Esophageal varix (HP:0002040) | 2.61847554 |
| 57 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.59663909 |
| 58 | Septate vagina (HP:0001153) | 2.58348427 |
| 59 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 2.56799969 |
| 60 | Abnormality of reticulocytes (HP:0004312) | 2.50843533 |
| 61 | Abnormal cartilage morphology (HP:0002763) | 2.49377218 |
| 62 | Acanthocytosis (HP:0001927) | 2.48112621 |
| 63 | Cortical dysplasia (HP:0002539) | 2.42069522 |
| 64 | Abnormality of glycolysis (HP:0004366) | 2.41076033 |
| 65 | Late onset (HP:0003584) | 2.38524975 |
| 66 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 2.38413470 |
| 67 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 2.38413470 |
| 68 | Hypoglycemic seizures (HP:0002173) | 2.35568181 |
| 69 | Spontaneous abortion (HP:0005268) | 2.35192234 |
| 70 | Back pain (HP:0003418) | 2.35093681 |
| 71 | Skin nodule (HP:0200036) | 2.33254453 |
| 72 | Ragged-red muscle fibers (HP:0003200) | 2.31474917 |
| 73 | Neonatal onset (HP:0003623) | 2.31075683 |
| 74 | Myocardial infarction (HP:0001658) | 2.28801692 |
| 75 | Lethargy (HP:0001254) | 2.26917292 |
| 76 | Metabolic acidosis (HP:0001942) | 2.24248613 |
| 77 | Pallor (HP:0000980) | 2.22548332 |
| 78 | Increased hepatocellular lipid droplets (HP:0006565) | 2.21654851 |
| 79 | Increased intramyocellular lipid droplets (HP:0012240) | 2.21531915 |
| 80 | Birth length less than 3rd percentile (HP:0003561) | 2.19736695 |
| 81 | Broad distal phalanx of finger (HP:0009836) | 2.18005034 |
| 82 | Abnormal number of erythroid precursors (HP:0012131) | 2.16523919 |
| 83 | Irritability (HP:0000737) | 2.14638824 |
| 84 | Breast carcinoma (HP:0003002) | 2.14511913 |
| 85 | Lipid accumulation in hepatocytes (HP:0006561) | 2.14266931 |
| 86 | Sensorimotor neuropathy (HP:0007141) | 2.13685242 |
| 87 | Aplastic anemia (HP:0001915) | 2.12715104 |
| 88 | Abnormality of transition element cation homeostasis (HP:0011030) | 2.11440520 |
| 89 | Abnormality of the umbilical cord (HP:0010881) | 2.10214123 |
| 90 | Truncus arteriosus (HP:0001660) | 2.09471218 |
| 91 | Abnormality of proline metabolism (HP:0010907) | 2.08723684 |
| 92 | Hydroxyprolinuria (HP:0003080) | 2.08723684 |
| 93 | Increased nuchal translucency (HP:0010880) | 2.08520721 |
| 94 | Poikilocytosis (HP:0004447) | 2.05755805 |
| 95 | Abnormality of the preputium (HP:0100587) | 2.05098009 |
| 96 | Vascular calcification (HP:0004934) | 2.03389084 |
| 97 | Increased muscle lipid content (HP:0009058) | 2.01503701 |
| 98 | Cerebral hypomyelination (HP:0006808) | 2.00407291 |
| 99 | Insomnia (HP:0100785) | 1.99594395 |
| 100 | Increased serum pyruvate (HP:0003542) | 1.99584698 |
| 101 | Cholelithiasis (HP:0001081) | 1.99529528 |
| 102 | Brushfield spots (HP:0001088) | 1.99063712 |
| 103 | Pancreatitis (HP:0001733) | 1.98909961 |
| 104 | Abnormality of the fetal cardiovascular system (HP:0010948) | 1.98658469 |
| 105 | Abnormal umbilical cord blood vessels (HP:0011403) | 1.98658469 |
| 106 | Single umbilical artery (HP:0001195) | 1.98658469 |
| 107 | Abnormality of the Achilles tendon (HP:0005109) | 1.97927613 |
| 108 | Cholecystitis (HP:0001082) | 1.95310945 |
| 109 | Abnormal gallbladder physiology (HP:0012438) | 1.95310945 |
| 110 | Nephroblastoma (Wilms tumor) (HP:0002667) | 1.94921774 |
| 111 | Sparse lateral eyebrow (HP:0005338) | 1.94873806 |
| 112 | Abnormal gallbladder morphology (HP:0012437) | 1.92668750 |
| 113 | Micronodular cirrhosis (HP:0001413) | 1.91740846 |
| 114 | Hyperglycemia (HP:0003074) | 1.90643541 |
| 115 | Abnormality of iron homeostasis (HP:0011031) | 1.90466829 |
| 116 | Medulloblastoma (HP:0002885) | 1.90124074 |
| 117 | Cutaneous melanoma (HP:0012056) | 1.90025872 |
| 118 | Oral leukoplakia (HP:0002745) | 1.89065317 |
| 119 | Rough bone trabeculation (HP:0100670) | 1.87742642 |
| 120 | Spinal cord lesions (HP:0100561) | 1.86086893 |
| 121 | Syringomyelia (HP:0003396) | 1.86086893 |
| 122 | Ileus (HP:0002595) | 1.85081640 |
| 123 | Abnormal large intestine physiology (HP:0012700) | 1.84799557 |
| 124 | Curly hair (HP:0002212) | 1.83967417 |
| 125 | Cerebral edema (HP:0002181) | 1.83777874 |
| 126 | Facial cleft (HP:0002006) | 1.83547257 |
| 127 | Upper limb muscle weakness (HP:0003484) | 1.83414892 |
| 128 | Hyperuricemia (HP:0002149) | 1.83359251 |
| 129 | Increased purine levels (HP:0004368) | 1.83359251 |
| 130 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 1.82962965 |
| 131 | Dicarboxylic aciduria (HP:0003215) | 1.82962965 |
| 132 | Hyperinsulinemic hypoglycemia (HP:0000825) | 1.82738071 |
| 133 | Bowel incontinence (HP:0002607) | 1.81800665 |
| 134 | Degeneration of anterior horn cells (HP:0002398) | 1.81750756 |
| 135 | Abnormality of the anterior horn cell (HP:0006802) | 1.81750756 |
| 136 | Proximal tubulopathy (HP:0000114) | 1.80914459 |
| 137 | Abnormality of chromosome stability (HP:0003220) | 1.79805787 |
| 138 | Reticulocytosis (HP:0001923) | 1.79791241 |
| 139 | Myelodysplasia (HP:0002863) | 1.79327973 |
| 140 | Long palpebral fissure (HP:0000637) | 1.79033593 |
| 141 | Cardiovascular calcification (HP:0011915) | 1.78697018 |
| 142 | Thrombophlebitis (HP:0004418) | 1.78181993 |
| 143 | Unilateral renal agenesis (HP:0000122) | 1.77981107 |
| 144 | Deep philtrum (HP:0002002) | 1.77521896 |
| 145 | Abnormality of the gallbladder (HP:0005264) | 1.77380813 |
| 146 | Ankyloglossia (HP:0010296) | 1.76804841 |
| 147 | Abnormality of the lower motor neuron (HP:0002366) | 1.76347194 |
| 148 | Multiple enchondromatosis (HP:0005701) | 1.75505521 |
| 149 | Orthostatic hypotension (HP:0001278) | 1.74714494 |
| 150 | Deep palmar crease (HP:0006191) | 1.74280242 |
| 151 | Short middle phalanx of the 5th finger (HP:0004220) | 1.73845795 |
| 152 | Overlapping toe (HP:0001845) | 1.73600497 |
| 153 | Neoplasm of the pancreas (HP:0002894) | 1.73558058 |
| 154 | Cafe-au-lait spot (HP:0000957) | 1.73542943 |
| 155 | Hypoparathyroidism (HP:0000829) | 1.73102040 |
| 156 | Embryonal renal neoplasm (HP:0011794) | 1.72873320 |
| 157 | Trismus (HP:0000211) | 1.72740313 |
| 158 | Clonus (HP:0002169) | 1.72727901 |
| 159 | Hyperparathyroidism (HP:0000843) | 1.71955591 |
| 160 | Increased serum lactate (HP:0002151) | 1.69989379 |
| 161 | Horseshoe kidney (HP:0000085) | 1.69212741 |
| 162 | Vomiting (HP:0002013) | 1.68956568 |
| 163 | Confusion (HP:0001289) | 1.68868601 |
| 164 | Glossoptosis (HP:0000162) | 1.68320046 |
| 165 | Proximal placement of thumb (HP:0009623) | 1.68031682 |
| 166 | Dysphonia (HP:0001618) | 1.67872039 |
| 167 | Rickets (HP:0002748) | 1.67856613 |
| 168 | Upper motor neuron abnormality (HP:0002127) | 1.67816122 |
| 169 | Death in infancy (HP:0001522) | 1.67421443 |
| 170 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 1.66375081 |
| 171 | Insidious onset (HP:0003587) | 1.66108410 |
| 172 | Termporal pattern (HP:0011008) | 1.66108410 |
| 173 | Megaloblastic anemia (HP:0001889) | 1.66030912 |
| 174 | Aplasia/Hypoplasia involving the carpal bones (HP:0006502) | 1.65830986 |
| 175 | Pseudobulbar signs (HP:0002200) | 1.65478803 |
| 176 | Systemic lupus erythematosus (HP:0002725) | 1.65422394 |
| 177 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 1.65293170 |
| 178 | Ankle clonus (HP:0011448) | 1.64863913 |
| 179 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.64754375 |
| 180 | Respiratory difficulties (HP:0002880) | 1.64437229 |
| 181 | Secondary amenorrhea (HP:0000869) | 1.63223493 |
| 182 | Status epilepticus (HP:0002133) | 1.63163368 |
| 183 | Death in childhood (HP:0003819) | 1.63054435 |
| 184 | Gastrointestinal carcinoma (HP:0002672) | 1.61604449 |
| 185 | Malignant gastrointestinal tract tumors (HP:0006749) | 1.61604449 |
| 186 | Mitral stenosis (HP:0001718) | 1.61179845 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 4.27042824 |
| 2 | NME2 | 3.62071328 |
| 3 | PKN2 | 3.35865274 |
| 4 | TRIB3 | 3.13221859 |
| 5 | FRK | 3.02033467 |
| 6 | PBK | 2.96279816 |
| 7 | SCYL2 | 2.88350266 |
| 8 | ERN1 | 2.63851368 |
| 9 | SMG1 | 2.37965682 |
| 10 | EPHA2 | 2.29873973 |
| 11 | MST1R | 2.28510237 |
| 12 | MAP3K10 | 2.26556903 |
| 13 | PRPF4B | 2.23829140 |
| 14 | CDK19 | 2.19973023 |
| 15 | LATS1 | 2.13808613 |
| 16 | ERBB4 | 2.05002983 |
| 17 | SIK1 | 2.04021780 |
| 18 | NEK1 | 1.97562167 |
| 19 | LATS2 | 1.80901281 |
| 20 | WEE1 | 1.78537911 |
| 21 | BUB1 | 1.76767177 |
| 22 | EIF2AK1 | 1.76293036 |
| 23 | FGFR4 | 1.75318619 |
| 24 | STK16 | 1.64409619 |
| 25 | PTK6 | 1.55881380 |
| 26 | TESK1 | 1.54065758 |
| 27 | ZAK | 1.46593182 |
| 28 | CDC7 | 1.46336448 |
| 29 | KSR2 | 1.45005360 |
| 30 | EEF2K | 1.43767401 |
| 31 | FLT3 | 1.41713607 |
| 32 | TESK2 | 1.40497051 |
| 33 | MAP3K9 | 1.37299055 |
| 34 | NEK2 | 1.36056971 |
| 35 | MARK1 | 1.33877753 |
| 36 | ACVR1B | 1.28967728 |
| 37 | RIPK1 | 1.27565657 |
| 38 | TTK | 1.26935374 |
| 39 | MAP3K2 | 1.25613224 |
| 40 | VRK2 | 1.24709337 |
| 41 | MAPK11 | 1.22375958 |
| 42 | MAP3K8 | 1.20902156 |
| 43 | MET | 1.15821272 |
| 44 | KDR | 1.15820568 |
| 45 | MAP3K11 | 1.15706183 |
| 46 | RPS6KB2 | 1.15147258 |
| 47 | IRAK3 | 1.10818209 |
| 48 | PLK4 | 1.05137107 |
| 49 | STK38L | 1.03055471 |
| 50 | MAP2K2 | 1.02859347 |
| 51 | CDK6 | 1.01157355 |
| 52 | RPS6KA4 | 1.00622171 |
| 53 | IRAK2 | 0.99454682 |
| 54 | ARAF | 0.98987379 |
| 55 | SIK3 | 0.97078314 |
| 56 | CDK12 | 0.96355866 |
| 57 | MAPKAPK3 | 0.94883165 |
| 58 | DYRK3 | 0.94662438 |
| 59 | MAP2K4 | 0.94259134 |
| 60 | DAPK1 | 0.92964904 |
| 61 | DAPK2 | 0.92407415 |
| 62 | CHEK1 | 0.92113456 |
| 63 | NEK6 | 0.91743659 |
| 64 | GRK6 | 0.90245909 |
| 65 | AURKA | 0.87923582 |
| 66 | KSR1 | 0.87612725 |
| 67 | BRD4 | 0.84749655 |
| 68 | ABL2 | 0.84084864 |
| 69 | PRKCI | 0.82513460 |
| 70 | CDK4 | 0.81693994 |
| 71 | FGFR2 | 0.81175239 |
| 72 | PTK2 | 0.80524203 |
| 73 | ICK | 0.80414451 |
| 74 | ERBB2 | 0.80258792 |
| 75 | PAK4 | 0.78989013 |
| 76 | AURKB | 0.78971268 |
| 77 | ILK | 0.78446409 |
| 78 | MTOR | 0.77823808 |
| 79 | TLK1 | 0.77157934 |
| 80 | MAP3K12 | 0.76303266 |
| 81 | TAOK3 | 0.76212420 |
| 82 | PLK1 | 0.75027984 |
| 83 | CLK1 | 0.74479177 |
| 84 | TGFBR1 | 0.73672527 |
| 85 | PDK2 | 0.71622957 |
| 86 | RAF1 | 0.71318368 |
| 87 | MST4 | 0.69611418 |
| 88 | CDK11A | 0.68926901 |
| 89 | LRRK2 | 0.68328214 |
| 90 | CDK14 | 0.68299573 |
| 91 | PLK3 | 0.68299182 |
| 92 | PDK4 | 0.67999899 |
| 93 | PDK3 | 0.67999899 |
| 94 | MAP3K5 | 0.67713521 |
| 95 | TRIM28 | 0.66911090 |
| 96 | BRAF | 0.66611031 |
| 97 | CAMKK1 | 0.65027589 |
| 98 | MAP2K1 | 0.64614081 |
| 99 | STK4 | 0.63712353 |
| 100 | PIM1 | 0.63463224 |
| 101 | MAP3K3 | 0.63407137 |
| 102 | DYRK1B | 0.62543399 |
| 103 | RPS6KB1 | 0.62429700 |
| 104 | MAP2K6 | 0.60426827 |
| 105 | VRK1 | 0.60315002 |
| 106 | CDK18 | 0.60176037 |
| 107 | CSNK1G3 | 0.60050710 |
| 108 | PRKCZ | 0.59848033 |
| 109 | CDK15 | 0.59641012 |
| 110 | PDGFRA | 0.59141533 |
| 111 | PASK | 0.58876375 |
| 112 | PIM2 | 0.58103230 |
| 113 | EIF2AK3 | 0.57782085 |
| 114 | STK3 | 0.57761312 |
| 115 | RET | 0.57704392 |
| 116 | SRPK1 | 0.57539048 |
| 117 | MELK | 0.57095320 |
| 118 | NME1 | 0.56686450 |
| 119 | CHEK2 | 0.55764655 |
| 120 | NEK9 | 0.55423965 |
| 121 | DYRK2 | 0.55041802 |
| 122 | AKT2 | 0.54947593 |
| 123 | RPS6KA5 | 0.52923938 |
| 124 | BRSK2 | 0.52490971 |
| 125 | MINK1 | 0.51053267 |
| 126 | ATM | 0.50758381 |
| 127 | TAOK1 | 0.48280929 |
| 128 | AKT3 | 0.48125635 |
| 129 | CDK1 | 0.48081270 |
| 130 | BRSK1 | 0.47065560 |
| 131 | PAK1 | 0.46210280 |
| 132 | TAF1 | 0.45862382 |
| 133 | FGFR1 | 0.44827512 |
| 134 | TAOK2 | 0.43520347 |
| 135 | TSSK6 | 0.42937915 |
| 136 | BMX | 0.41336649 |
| 137 | MAP2K7 | 0.40149859 |
| 138 | CSNK1E | 0.40076124 |
| 139 | ATR | 0.39948967 |
| 140 | CDK7 | 0.39547231 |
| 141 | CSNK1A1L | 0.39446635 |
| 142 | JAK2 | 0.39434408 |
| 143 | STK10 | 0.39269434 |
| 144 | DAPK3 | 0.37215944 |
| 145 | CSNK2A1 | 0.37015554 |
| 146 | ALK | 0.36401106 |
| 147 | MAP2K3 | 0.32620460 |
| 148 | CDK2 | 0.32578605 |
| 149 | CSNK2A2 | 0.31850380 |
| 150 | PRKAA1 | 0.31313826 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.10814150 |
| 2 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.57342148 |
| 3 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.41007618 |
| 4 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.38582921 |
| 5 | Ribosome_Homo sapiens_hsa03010 | 3.17987982 |
| 6 | Arginine biosynthesis_Homo sapiens_hsa00220 | 3.15340170 |
| 7 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.84218015 |
| 8 | Base excision repair_Homo sapiens_hsa03410 | 2.57233124 |
| 9 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.57209452 |
| 10 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.48198554 |
| 11 | Selenocompound metabolism_Homo sapiens_hsa00450 | 2.25669034 |
| 12 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.21549714 |
| 13 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.19594807 |
| 14 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.19574268 |
| 15 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.09700918 |
| 16 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.09004507 |
| 17 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 2.01871784 |
| 18 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.99794474 |
| 19 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.97262411 |
| 20 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.92942158 |
| 21 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.90054965 |
| 22 | RNA polymerase_Homo sapiens_hsa03020 | 1.83571169 |
| 23 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.83489043 |
| 24 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.82863997 |
| 25 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.77801416 |
| 26 | Peroxisome_Homo sapiens_hsa04146 | 1.74502784 |
| 27 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.73218967 |
| 28 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.70812590 |
| 29 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.68065908 |
| 30 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.67882656 |
| 31 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.65946287 |
| 32 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.63045217 |
| 33 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.58699416 |
| 34 | Bile secretion_Homo sapiens_hsa04976 | 1.58544645 |
| 35 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.57912752 |
| 36 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.57795430 |
| 37 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.55777589 |
| 38 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.55727068 |
| 39 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.53773572 |
| 40 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.48542388 |
| 41 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.45023538 |
| 42 | Histidine metabolism_Homo sapiens_hsa00340 | 1.42782611 |
| 43 | Carbon metabolism_Homo sapiens_hsa01200 | 1.40294664 |
| 44 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.36977066 |
| 45 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.36926901 |
| 46 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.35708612 |
| 47 | Homologous recombination_Homo sapiens_hsa03440 | 1.32672762 |
| 48 | Retinol metabolism_Homo sapiens_hsa00830 | 1.32230816 |
| 49 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.31150458 |
| 50 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.31132960 |
| 51 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.28287220 |
| 52 | Alcoholism_Homo sapiens_hsa05034 | 1.27391532 |
| 53 | Sulfur relay system_Homo sapiens_hsa04122 | 1.26068820 |
| 54 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.23690579 |
| 55 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.23399541 |
| 56 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.17969214 |
| 57 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.17852498 |
| 58 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.16042828 |
| 59 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.09794726 |
| 60 | Viral carcinogenesis_Homo sapiens_hsa05203 | 1.06333211 |
| 61 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.02872945 |
| 62 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.99075112 |
| 63 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.98876622 |
| 64 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.97458148 |
| 65 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.96554836 |
| 66 | Purine metabolism_Homo sapiens_hsa00230 | 0.96375640 |
| 67 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.95409893 |
| 68 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.90855844 |
| 69 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.90664119 |
| 70 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.89393644 |
| 71 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.88519158 |
| 72 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.87296649 |
| 73 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.86608652 |
| 74 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.86098418 |
| 75 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.85526287 |
| 76 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.82844819 |
| 77 | RNA degradation_Homo sapiens_hsa03018 | 0.82745537 |
| 78 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.81159548 |
| 79 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.79748476 |
| 80 | Colorectal cancer_Homo sapiens_hsa05210 | 0.79458281 |
| 81 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.78988510 |
| 82 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.77807641 |
| 83 | Lysine degradation_Homo sapiens_hsa00310 | 0.77359244 |
| 84 | Parkinsons disease_Homo sapiens_hsa05012 | 0.73988779 |
| 85 | Shigellosis_Homo sapiens_hsa05131 | 0.73173740 |
| 86 | ABC transporters_Homo sapiens_hsa02010 | 0.72836417 |
| 87 | Huntingtons disease_Homo sapiens_hsa05016 | 0.72001871 |
| 88 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.68103663 |
| 89 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.66920204 |
| 90 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.66456015 |
| 91 | Basal transcription factors_Homo sapiens_hsa03022 | 0.65266119 |
| 92 | Glioma_Homo sapiens_hsa05214 | 0.64955066 |
| 93 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.63504914 |
| 94 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.63179227 |
| 95 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.63043289 |
| 96 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.61586663 |
| 97 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.58444754 |
| 98 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.57676999 |
| 99 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.57402039 |
| 100 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.54182125 |
| 101 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.52328172 |
| 102 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.51283243 |
| 103 | Hepatitis B_Homo sapiens_hsa05161 | 0.51107394 |
| 104 | Prostate cancer_Homo sapiens_hsa05215 | 0.50447625 |
| 105 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.47607028 |
| 106 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.46190811 |
| 107 | Galactose metabolism_Homo sapiens_hsa00052 | 0.45075219 |
| 108 | Protein export_Homo sapiens_hsa03060 | 0.44984322 |
| 109 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.43833728 |
| 110 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.43687866 |
| 111 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.43252701 |
| 112 | Metabolic pathways_Homo sapiens_hsa01100 | 0.43233173 |
| 113 | Proteasome_Homo sapiens_hsa03050 | 0.42805930 |
| 114 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.40425579 |
| 115 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.39698341 |
| 116 | RNA transport_Homo sapiens_hsa03013 | 0.39206818 |
| 117 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.39082487 |
| 118 | Apoptosis_Homo sapiens_hsa04210 | 0.38771610 |
| 119 | Prion diseases_Homo sapiens_hsa05020 | 0.38400317 |
| 120 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.37921395 |
| 121 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.35322611 |
| 122 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.35155783 |
| 123 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.35132196 |
| 124 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.34994700 |
| 125 | DNA replication_Homo sapiens_hsa03030 | 0.34041583 |
| 126 | Bladder cancer_Homo sapiens_hsa05219 | 0.32361937 |
| 127 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.32238611 |
| 128 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.31850992 |
| 129 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.24752596 |
| 130 | Insulin resistance_Homo sapiens_hsa04931 | 0.24515883 |
| 131 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.23449387 |
| 132 | Thyroid cancer_Homo sapiens_hsa05216 | 0.21676419 |
| 133 | Mismatch repair_Homo sapiens_hsa03430 | 0.21541885 |
| 134 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.20618131 |
| 135 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.20445196 |
| 136 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.19453960 |
| 137 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.14882347 |
| 138 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.12739720 |
| 139 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.12237350 |
| 140 | Cell cycle_Homo sapiens_hsa04110 | 0.04930991 |
| 141 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.04082007 |
| 142 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.02318350 |
| 143 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.02277345 |
| 144 | Endometrial cancer_Homo sapiens_hsa05213 | 0.01178241 |
| 145 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.00984288 |
| 146 | Spliceosome_Homo sapiens_hsa03040 | 0.00808090 |
| 147 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.00302546 |
| 148 | mTOR signaling pathway_Homo sapiens_hsa04150 | -0.0311005 |
| 149 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | -0.0209185 |
| 150 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | -0.0142193 |

